NNC0662-0419
/ Novo Nordisk
- LARVOL DELTA
Home
Next
Prev
1 to 17
Of
17
Go to page
1
September 16, 2026
A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity
(clinicaltrials.gov)
- P2 | N=233 | Active, not recruiting | Sponsor: Novo Nordisk A/S | Recruiting ➔ Active, not recruiting
Enrollment closed • Genetic Disorders • Obesity
July 11, 2026
A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity
(clinicaltrials.gov)
- P2 | N=230 | Recruiting | Sponsor: Novo Nordisk A/S | Not yet recruiting ➔ Recruiting
Enrollment open • Genetic Disorders • Obesity
June 11, 2026
A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity
(clinicaltrials.gov)
- P2 | N=230 | Not yet recruiting | Sponsor: Novo Nordisk A/S
New P2 trial • Genetic Disorders • Obesity
May 07, 2026
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
(clinicaltrials.gov)
- P2 | N=270 | Recruiting | Sponsor: Novo Nordisk A/S | Not yet recruiting ➔ Recruiting
Enrollment open • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus • CST3
April 30, 2026
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
(clinicaltrials.gov)
- P2 | N=145 | Recruiting | Sponsor: Novo Nordisk A/S | N=110 ➔ 145 | Not yet recruiting ➔ Recruiting
Enrollment change • Enrollment open • Trial initiation date • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus • CST3
April 27, 2026
NN9662-8160: A research study comparing how well different doses of the medicine NNC0662-0419 lower blood sugar in people with type 2 diabetes
(clinicaltrialsregister.eu)
- P1/2 | N=110 | Not yet recruiting | Sponsor: Novo Nordisk A/S
New P1/2 trial • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
April 28, 2026
A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or Obesity
(clinicaltrials.gov)
- P2 | N=224 | Active, not recruiting | Sponsor: Novo Nordisk A/S | Recruiting ➔ Active, not recruiting
Enrollment closed • Genetic Disorders • Obesity
April 25, 2026
A Research Study Looking Into How NNC0662-0419 Works With Birth Control Pills and Emptying of the Stomach in Women Not Able to Become Pregnant With Excess Body Weight
(clinicaltrials.gov)
- P1 | N=45 | Recruiting | Sponsor: Novo Nordisk A/S | Not yet recruiting ➔ Recruiting
Enrollment open • Genetic Disorders • Long-acting Reversible Contraceptives • Obesity
April 14, 2026
A Research Study Looking Into How NNC0662-0419 Works With Birth Control Pills and Emptying of the Stomach in Women Not Able to Become Pregnant With Excess Body Weight
(clinicaltrials.gov)
- P1 | N=45 | Not yet recruiting | Sponsor: Novo Nordisk A/S
New P1 trial • Genetic Disorders • Long-acting Reversible Contraceptives • Obesity
February 18, 2026
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
(clinicaltrials.gov)
- P2 | N=270 | Not yet recruiting | Sponsor: Novo Nordisk A/S
New P2 trial • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus • CST3
December 24, 2025
A Research Study on How a Dose of NNC0662-0419 Works in Japanese, Chinese and Non-Asian Participants Living With Overweight or Obesity
(clinicaltrials.gov)
- P1 | N=100 | Completed | Sponsor: Novo Nordisk A/S | Recruiting ➔ Completed
Trial completion • Genetic Disorders • Obesity
October 22, 2025
A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or Obesity
(clinicaltrials.gov)
- P2 | N=220 | Recruiting | Sponsor: Novo Nordisk A/S | Not yet recruiting ➔ Recruiting
Enrollment open • Genetic Disorders • Obesity
September 22, 2025
A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or Obesity
(clinicaltrials.gov)
- P2 | N=220 | Not yet recruiting | Sponsor: Novo Nordisk A/S
New P2 trial • Genetic Disorders • Obesity
September 04, 2025
A First-in-human Research Study on How NNC0662-0419 Works in People Living With Overweight or Obesity
(clinicaltrials.gov)
- P1 | N=100 | Completed | Sponsor: Novo Nordisk A/S | Recruiting ➔ Completed
Trial completion • Genetic Disorders • Obesity
August 18, 2025
A Research Study on How a Dose of NNC0662-0419 Works in Japanese, Chinese and Non-Asian Participants Living With Overweight or Obesity
(clinicaltrials.gov)
- P1 | N=99 | Recruiting | Sponsor: Novo Nordisk A/S | Not yet recruiting ➔ Recruiting
Enrollment open • Genetic Disorders • Obesity
August 05, 2025
A Research Study on How a Dose of NNC0662-0419 Works in Japanese, Chinese and Non-Asian Participants Living With Overweight or Obesity
(clinicaltrials.gov)
- P1 | N=99 | Not yet recruiting | Sponsor: Novo Nordisk A/S
New P1 trial • Genetic Disorders • Obesity
January 07, 2025
A First-in-human Research Study on How NNC0662-0419 Works in People Living With Overweight or Obesity
(clinicaltrials.gov)
- P1 | N=100 | Recruiting | Sponsor: Novo Nordisk A/S | Not yet recruiting ➔ Recruiting
Enrollment open • Genetic Disorders • Obesity
1 to 17
Of
17
Go to page
1